[go: up one dir, main page]

MA67594A1 - Composition aqueuse - Google Patents

Composition aqueuse

Info

Publication number
MA67594A1
MA67594A1 MA67594A MA67594A MA67594A1 MA 67594 A1 MA67594 A1 MA 67594A1 MA 67594 A MA67594 A MA 67594A MA 67594 A MA67594 A MA 67594A MA 67594 A1 MA67594 A1 MA 67594A1
Authority
MA
Morocco
Prior art keywords
aqueous composition
ester
acceptable salt
pharmacologically acceptable
relates
Prior art date
Application number
MA67594A
Other languages
English (en)
Inventor
Rika ORITANI
Chise KITANI
Akinori Nishimoto
Original Assignee
Tsubota Laboratory, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tsubota Laboratory, Inc. filed Critical Tsubota Laboratory, Inc.
Publication of MA67594A1 publication Critical patent/MA67594A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/1468—Containers characterised by specific material properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

Une première invention concerne une composition aqueuse qui contient (A) de l'acide 4-phénylbutyrique ou un ester de celui-ci, ou un sel pharmacologiquement acceptable de celui-ci, et qui est logée dans un récipient dans lequel tout ou une partie de celle-ci en contact avec la composition aqueuse est formée d'une résine contenant une polyoléfine. Une seconde invention concerne une composition aqueuse contenant (A) de l'acide 4-phénylbutyrique ou un ester de celui-ci, ou un sel pharmacologiquement acceptable de celui-ci, et (B) un agent chélatant.
MA67594A 2022-03-25 2023-03-24 Composition aqueuse MA67594A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2022050275 2022-03-25
PCT/JP2023/011739 WO2023182480A1 (fr) 2022-03-25 2023-03-24 Composition aqueuse

Publications (1)

Publication Number Publication Date
MA67594A1 true MA67594A1 (fr) 2025-07-31

Family

ID=88101709

Family Applications (1)

Application Number Title Priority Date Filing Date
MA67594A MA67594A1 (fr) 2022-03-25 2023-03-24 Composition aqueuse

Country Status (14)

Country Link
US (1) US20250213510A1 (fr)
EP (1) EP4483867A1 (fr)
JP (1) JPWO2023182480A1 (fr)
KR (1) KR20240159636A (fr)
CN (1) CN118973561A (fr)
AU (1) AU2023240729A1 (fr)
CA (1) CA3254664A1 (fr)
CL (1) CL2024002831A1 (fr)
IL (1) IL315871A (fr)
MA (1) MA67594A1 (fr)
MX (1) MX2024011634A (fr)
PE (1) PE20250746A1 (fr)
TW (1) TW202400133A (fr)
WO (1) WO2023182480A1 (fr)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005330271A (ja) * 2004-04-20 2005-12-02 Taisho Pharmaceut Co Ltd 点眼用液剤
JP2013525451A (ja) * 2010-04-28 2013-06-20 ザ・チャイニーズ・ユニバーシティ・オブ・ホンコン 高眼圧症及び緑内障を予防及び治療する方法及び薬物
JP2016065095A (ja) * 2008-05-30 2016-04-28 参天製薬株式会社 高眼圧症及び緑内障を治療するための方法及び組成物
WO2018164113A1 (fr) * 2017-03-06 2018-09-13 学校法人 慶應義塾 Modèle murin d'induction de la myopie et inhibiteur de stress du réticulum endoplasmique pour prévenir ou supprimer la myopie
WO2018181294A1 (fr) * 2017-03-27 2018-10-04 興和株式会社 Préparation pharmaceutique
WO2020129965A1 (fr) * 2018-12-18 2020-06-25 参天製薬株式会社 Agent contenant du 4-phénylbutyrate, pour la prévention ou le traitement de la presbytie

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070004805A1 (en) * 2005-07-01 2007-01-04 Navinta Llc Process for preparation of liquid dosage form containing sodium 4-phenylbutyrate
JP2009078977A (ja) * 2007-09-25 2009-04-16 Japan Health Science Foundation 心筋の小胞体ストレス抑制剤

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005330271A (ja) * 2004-04-20 2005-12-02 Taisho Pharmaceut Co Ltd 点眼用液剤
JP2016065095A (ja) * 2008-05-30 2016-04-28 参天製薬株式会社 高眼圧症及び緑内障を治療するための方法及び組成物
JP2013525451A (ja) * 2010-04-28 2013-06-20 ザ・チャイニーズ・ユニバーシティ・オブ・ホンコン 高眼圧症及び緑内障を予防及び治療する方法及び薬物
WO2018164113A1 (fr) * 2017-03-06 2018-09-13 学校法人 慶應義塾 Modèle murin d'induction de la myopie et inhibiteur de stress du réticulum endoplasmique pour prévenir ou supprimer la myopie
WO2018181294A1 (fr) * 2017-03-27 2018-10-04 興和株式会社 Préparation pharmaceutique
WO2020129965A1 (fr) * 2018-12-18 2020-06-25 参天製薬株式会社 Agent contenant du 4-phénylbutyrate, pour la prévention ou le traitement de la presbytie

Also Published As

Publication number Publication date
MX2024011634A (es) 2024-09-30
AU2023240729A1 (en) 2024-10-03
IL315871A (en) 2024-11-01
CL2024002831A1 (es) 2025-01-24
KR20240159636A (ko) 2024-11-05
TW202400133A (zh) 2024-01-01
US20250213510A1 (en) 2025-07-03
EP4483867A1 (fr) 2025-01-01
CN118973561A (zh) 2024-11-15
PE20250746A1 (es) 2025-03-13
CA3254664A1 (fr) 2025-07-03
JPWO2023182480A1 (fr) 2023-09-28
WO2023182480A1 (fr) 2023-09-28

Similar Documents

Publication Publication Date Title
Brill et al. The passage of tissue fluid into the clinically healthy gingival pocket
Otto et al. Cysteine proteases and their inhibitors
Winum et al. Therapeutic potential of sulfamides as enzyme inhibitors
FR2424311A1 (fr) Compositions de nettoyage pour des lentilles de contact, a base d'uree ou d'un sel d'acide avec la guanidine, et d'un reducteur
MA67594A1 (fr) Composition aqueuse
BR0313970A (pt) Composições pesticidas contendo ácidos dicarboxìlicos
FR2396076A1 (fr) Composition detergente contenant un carbonate alcalin
FR2410630A1 (fr) Procede pour preparer des composes de type pyrochlore riches en plomb et riches en bismuth avec un milieu alcalin
FR2356600A1 (fr) Agent germicide pour systemes aqueux a base de peroxyde d'hydrogene et son utilisation
BE1003188A4 (fr) Composition pharmaceutique destinee a etre administree par voie orale et contenant de la n-acetyl-cysteine, et son application.
ES2053525T3 (es) Acidos hidroxamicos.
Roy The sulphatase of ox liver. 4. A note on the inhibition of sulphatases A and B
WO2019144692A1 (fr) Agent de protection du glucagon et son utilisation
CO5670371A2 (es) Composiciones limpiadoras en la forma de una tableta
MA30600B1 (fr) Formulation medicamenteuse aqueuse d'acide 4-[((4-carboxybutyl)-{2-[(4-phenethyl-benzyl)oxy]-phenethyl}amino)methyl]benzoique.
CN104059794A (zh) 一种分析仪的清洗液
Stauber et al. Fluorescence demonstration of cathepsin B activity in skeletal, cardiac, and vascular smooth muscle.
FR2980974A1 (fr) Composition comprenant un sel d'hypothiocyanite d'un cation alcalin, a l'etat solide
FR2381526A1 (fr) Nouvelles combinaisons medicamenteuses et procede pour leur fabrication
FR3086866B1 (fr) Kit comprenant deux compositions separees, notamment pour une application cosmetique
DE69807059D1 (de) Enzym-konzentrat
FR2444726A1 (fr) Electrolyte contenant de l'acide thiodiglycollique destine au depot d'" or blanc "
Ojala Interpreting Late Bronze Age Uppland: Regional identity and interregional contacts
FR3089419B1 (fr) Composition de matière nettoyante
Infante et al. Enzyme activity in anuran spermatozoa upon induction of the acrosome reaction